Corsair Pharma Announces Successful Completion of Preclinical Program for Its Treprostinil Prodrug Transdermal System ...

Inc. (NS Pharma), a subsidiary of Nippon Shinyaku Co., Ltd. (Nippon Shinyaku), announced today that acceptance has been received by Capricor Therapeutics, Inc. (Headquarters: California, USA, CEO ...

Companies need their news to generate value. Business Wire's extensive experience, industry knowledge, and superior media ...

Stoke Therapeutics (STOK) announced that Edward Kaye has decided to step down from his role as CEO effective as of March 19. To facilitate a ...

Dr. Baumgartner joins Applied as an accomplished global drug development leader with over 35 years of experience in senior regulatory, clinical development, and medical affairs roles. He has held a ...

Noel was promoted to the position previously held by Brian Thompson, who was killed in an early morning shooting in December ...

Brent Pfeiffenberger, President and CEO of Century Therapeutics , Inc. (NASDAQ:IPSC), recently executed a transaction involving the sale of 2,235 shares of the company’s common stock. The shares were ...

Building a climate-controlled warehouse and logistics facility for United Therapeutics in North Carolina’s Research Triangle was a matter of power management and careful planning. The facility ...

United Therapeutics Co. has a fifty-two week low of $221.53 and a fifty-two week high of $417.82. The company has a market cap of $13.80 billion, a PE ratio of 13.49, a price-to-earnings-growth ...

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life ...

We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against ...